NCT05641636

Brief Summary

The purpose of research is to study to adverse cardiovascular disorder and risks factors in childhood cranial and craniospinal tumors survivors. In this research the investigators investigate cardiological instrumental diagnostic, such as electrocardiography, echocardiography with the determination of global longitudinal strain, cardiopulmonary exercise test, and diagnostic of endothelial function by Angioscan for the prediction of cardiovascular complications after cranial and craniospinal radiotherapy and chemotherapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 11, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 27, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 7, 2022

Completed
Last Updated

December 7, 2022

Status Verified

November 1, 2022

Enrollment Period

2.1 years

First QC Date

November 27, 2022

Last Update Submit

December 6, 2022

Conditions

Keywords

brain tumors in childrenrisk of cardiovascular diseaseradiation therapydyslipidemiaendothelial dysfunctioncardiopulmonary testing

Outcome Measures

Primary Outcomes (3)

  • Dyslipidemia

    change сoncentration of total cholesterol \>5 mmol/l, change сoncentration of LDL \> 3 mmol/l, сoncentration of HDL \<1,2 mmol/l, change сoncentration of TG \>1,7 mmol/

    At baseline and through study completion of 1 year

  • endotelian dysfunction

    change in endothelial function by Angioscan

    At baseline and through study completion of 1 year

  • change in exercise tolerance

    change anaerobic threshold\<14,0 ml/kg/min

    At baseline and through study completion of 1 year

Study Arms (2)

childhood cancer survivors - the main group

childhood cancer survivals after complex management of cranial and craniospinal tumors formed the main group

Diagnostic Test: 12-lead ECG, hormone and lipid blood tests, echocardiography (Echo-CG), cardiopulmonary exercise testing (CPET) and pulse wave analysis

the control group

healthy people formed the control group

Diagnostic Test: 12-lead ECG, hormone and lipid blood tests, echocardiography (Echo-CG), cardiopulmonary exercise testing (CPET) and pulse wave analysis

Interventions

Echocardiography - standart protocol. Pulse wave characteristics were obtained using finger photopletysmography (PPG) (Angioscan-01, AngioScan-Electronics) from an infrared light sensor. Endothelial function was also evaluated using occlusion index and shear rate during post-occlusive reactive hyperemia (PORH). CPET was conducted on a treadmill (Intertrack 8100, Schiller, Switzerland) with a breath-by-breath algorithm of gas exchange analysis (Cardiovit CS-200 Ergo-Spiro, Schiller, Switzerland), using Bruce, modified Bruce or Naughton protocols depending on the level of physical tolerance.

childhood cancer survivors - the main groupthe control group

Eligibility Criteria

Age16 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

childhood cancer survivals after complex management of cranial and craniospinal tumors formed the main group

You may qualify if:

  • radiation and chemotherapy for cranial and craniospinal tumors in childhood or adolescence
  • completion of the therapy at least one year before enrollment
  • signed informed consent
  • there were three separate types of informed consent - for adults, for minors and for their parents
  • minors were signing informed consent in the presence of their parents.

You may not qualify if:

  • standard contraindications to exercise testing
  • anemia, pregnancy
  • psychiatric disease
  • alcohol or drug abuse
  • active malignancy
  • acute infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Moscow, Russia

Location

MeSH Terms

Conditions

Central Nervous System NeoplasmsDyslipidemias

Interventions

ElectrocardiographyEchocardiographyExercise TestPulse Wave Analysis

Condition Hierarchy (Ancestors)

Nervous System NeoplasmsNeoplasms by SiteNeoplasmsNervous System DiseasesLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisCardiac Imaging TechniquesDiagnostic ImagingUltrasonographyRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2022

First Posted

December 7, 2022

Study Start

November 11, 2019

Primary Completion

December 30, 2021

Study Completion

October 28, 2022

Last Updated

December 7, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations